Total investments received (USD): 125.31m
Round value (USD): 28.34m
Round investors:
Forbion Capital Partners
Novo A/S
Company: Orbis Medicines










Belgium
Austria
Germany
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal
Spain
United Kingdom